Recalls
When a product is unsafe or breaks the rules, the company pulls it back and FDA classes the recall. Class I could cause serious harm or death. Class II could cause temporary harm. Class III is unlikely to hurt anyone.
5,412 recalls in the last 12 months. Newest first.
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Dec 10, 2025 | Class II | Hale inc Food |
Lotsa Pasta International Food Shop Fresh Basil Infused Olive Oil, Net Wt. 12 oz. (375ml), packaged in a glass bottle, UPC 736211448316, packed 12 bottles per case Potential to be contaminated with Clostridium botulinum. Products manufactured without an approved process filed. FDA notice H-0241-2026 |
| Dec 10, 2025 | Class II | Blossom Pharmaceuticals Drug |
WeCare, Zinc Oxide Ointment, Net Wt. 15 oz/425 g, Manuactured for: Dynarex Corporation, 11 Dynarex Drive, Middletown, NY 10941, Made in India, NDC 67777-223-05. cGMP deviations FDA notice D-0205-2026 |
| Dec 10, 2025 | Class II | Blossom Pharmaceuticals Drug |
Dynagel, Moisturizing Wound Hydrogel, Net Wt. 3oz (84.7 g), Manufactured for: Dynarex Corporation, 16 Glenshaw Street, Orangeburg, NY 10962, UPC 61784128016. cGMP deviations FDA notice D-0204-2026 |
| Dec 10, 2025 | Class II | Blossom Pharmaceuticals Drug |
Globe Clotrimazole Cream USP, 1 % Antifungal Cream, Net Wt., 5 oz. (142 g, Distributed by: Trifecta Pharmaceuticals USA, 101 NE Third Avenue, Suite 1500, Ft. Lauderdale, FL 33301, USA, NDC 69396-087-55. cGMP deviations FDA notice D-0211-2026 |
| Dec 10, 2025 | Class II | Blossom Pharmaceuticals Drug |
Nivagen, Zinc Oxide Ointment, Net Wt. 1 oz. (28.4g), Nivagen Pharmaceuticals, Inc., Sacramento, CA 95827, USA Made in India, NDC 75834-170-01. cGMP deviations FDA notice D-0208-2026 |
| Dec 10, 2025 | Class II | Blossom Pharmaceuticals Drug |
Lanashield Skin Barrier, 4 oz. (113 g), Manfuactured for: Dynarex Corporation, 10 Gleshaw Street, Orangeburg, NY 10962 USA, Made in India, UPC 616784126319. cGMP deviations FDA notice D-0201-2026 |
| Dec 10, 2025 | Class II | Blossom Pharmaceuticals Drug |
Globe Clotrimazole Cream, USP, 1 %, Net Wt. 1 oz (28.4g), Distributed by: Trifecta Pharmaceuticals USA, 101 NE Third Avenue, Suite 1500, Ft. Lauderdale, FL 33301 USA, Made in India, NDC 69396-087-01. cGMP deviations FDA notice D-0210-2026 |
| Dec 10, 2025 | Class II | Cipla Limited Drug |
Phytonadione Injectable Emulsion, USP 10mg/mL, 10x1 mL Single-Dose Vial/carton, Rx Only, Mfd. by: Cipla Ltd. India At M/s Immacule Lifesciences PVT. Ltd. India. Mfd. for: Cipla USA, Inc. Warren, NJ 07059. Vial NDC# 69097… Failed Stability Specifications: Observed OOS results: eg results for colour index FDA notice D-0197-2026 |
| Dec 10, 2025 | Class II | Blossom Pharmaceuticals Drug |
Nivagen, Zinc Oxide Ointment USP, Zinc Oxide 20 %, Net Wt. 1 oz. (28.4g), Nivagen Pharmaceuticals, Inc., Sacramento, CA 95827, USA, Made in India, NDC 75834-170-02. cGMP deviations FDA notice D-0209-2026 |
| Dec 10, 2025 | Class III | Teva Pharmaceuticals USA, Inc Drug |
Carton label: Testosterone Gel 1%, 2.5 grams per unit dose, CIII, 30 unit-dose packets, Rx only, Manufactured by: Actavis Laboratories, Inc, Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc., Parsippany, NJ … Defective Container - A defect in the side-seal which allows leakage of product. FDA notice D-0198-2026 |
| Dec 10, 2025 | Class II | Blossom Pharmaceuticals Drug |
Dynashield, 4 oz cream (113 g), Manufactured for: Dynarex Corporation, 10 Glenshaw Street, Orangeburg, NY 10852, USA, Made in India, NDC 67777-407-03. cGMP deviations FDA notice D-0207-2026 |
| Dec 10, 2025 | Class II | Breckenridge Pharmaceutical, Inc. Drug |
Duloxetine Delayed-Release Capsules, USP, 60 mg, 1000-Capsule bottles, Rx Only, Manufactured by: Towa Pharmaceuticals Europe, S.L. Marotrelles, (Barcelona), Spain, Manufactured for : Quallient Pharmaceuticals Health, LLC… CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit FDA notice D-0215-2026 |
| Dec 10, 2025 | Class II | Blossom Pharmaceuticals Drug |
Wecare Calasoothe, Net wt. 4 oz (113 g), Manufactured for: Dynarex Corporation, 10 Glenshaw Street, Orangeburg, NY 10962, NDC 67777-234-04. cGMP deviations FDA notice D-0213-2026 |
| Dec 10, 2025 | Class II | Blossom Pharmaceuticals Drug |
Wecare Enema, 4.5 Fl Oz/133mL, Manufactured for: Dynarex Corporation, 11 Dynarex Corporation, MIddletown, NY 10941 USA, Made in India, NDC 67777-402-01. cGMP deviations FDA notice D-0203-2026 |
| Dec 10, 2025 | Class II | Blossom Pharmaceuticals Drug |
Dynashield Skin Protectant, Net Wt. 16 oz (453.6 g), Manufactured for: Dyrnarex Corporation, 10 Glenshaw Street, Orangeburg, NY 10962, USA, Made in India, NDC 67777-407-04. cGMP deviations FDA notice D-0202-2026 |
| Dec 10, 2025 | Class II | Breckenridge Pharmaceutical, Inc. Drug |
Duloxetine Delayed-Release Capsules, USP, 60 mg, 1000-Capsule bottles, Rx Only, Manufactured by: Towa Pharmaceuticals Europe, S.L. Marotrelles, (Barcelona), Spain, Distributed by: Breckenridge Pharmaceutical Inc., Berkel… CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit FDA notice D-0216-2026 |
| Dec 10, 2025 | Class II | Park Avenue Compounding Drug |
Phenylephrine HCI, 1000 mcg / 10 mL, 10 mL Total Volume, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint Louis, MO, 63110-2512, NDC 83863-0104-1. CGMP Deviations FDA notice D-0200-2026 |
| Dec 10, 2025 | Class II | Blossom Pharmaceuticals Drug |
Nivagen Pharmaceuticals, Zinc Oxide Ointment USP, Zinc Oxide 20% Skin Protectant, Net Wt. 15 oz (425g), Made in India, Manufactured for: Nivagen Pharmaceuticals, Inc., Sacramento, CA 95827, USA, NDC 75834-170-15. cGMP deviations FDA notice D-0206-2026 |
| Dec 10, 2025 | Class II | Safecor Health, LLC Drug |
Haloperidol Lactate Injection, 5 mg/mL, 25 x 1 mL Single-Dose Vials, Sterile, Rx only, For Intramuscular Use Only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26605. NDC: 67457-426-12 with Safecor Health … Labeling: Not Elsewhere Classified:Incorrect RFID tag labels applied to product by repackaging firm. FDA notice D-0214-2026 |
| Dec 10, 2025 | Class II | Blossom Pharmaceuticals Drug |
Globe Zinc Oxide Ointment USP Zinc Oxide 20% Skin Protectant, Net Wt. 2 oz (56.7 g), Distributed by: Trifecta Pharmaceuticals USA 101 NE, Third Avenue, Suite 1500, Ft. Lauderdale, FL 33301, NDC 69396-086-02. cGMP deviations FDA notice D-0212-2026 |
| Dec 10, 2025 | Class III | Glenmark Pharmaceuticals Inc., USA Drug |
Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, 2.5 mg/6.25 mg, packaged as (a) 30-count bottles, NDC-68462-878-30; (b) 100-count bottle, NDC-68462-878-01; (c) 500-count bottles, NDC-68462-878-05; Rx Only, Manu… Cross Contamination with Other Products: Testing of reserve samples showed presence of traces of ezetimibe FDA notice D-0199-2026 |
| Dec 10, 2025 | Class II | GET TESTED INTERNATIONAL AB Device |
Continuous Glucose Monitor (CGM) Distribution without premarket approval/clearance. FDA notice Z-0770-2026 |
| Dec 10, 2025 | Class II | Philips North America Llc Device |
IntelliVue MP70. Product Number: M8007A. Potential issue where the IntelliVue monitors did not alarm. FDA notice Z-0856-2026 |
| Dec 10, 2025 | Class II | GET TESTED INTERNATIONAL AB Device |
Estrogen & Progesterone Test Distribution without premarket approval/clearance. FDA notice Z-0805-2026 |
| Dec 10, 2025 | Class II | GET TESTED INTERNATIONAL AB Device |
Gut Microbiome Test Medium Distribution without premarket approval/clearance. FDA notice Z-0779-2026 |
| Dec 10, 2025 | Class II | GET TESTED INTERNATIONAL AB Device |
Vaginal PH Test Distribution without premarket approval/clearance. FDA notice Z-0755-2026 |
| Dec 10, 2025 | Class II | GET TESTED INTERNATIONAL AB Device |
Environmental Pollutants Profile Test Distribution without premarket approval/clearance. FDA notice Z-0758-2026 |
| Dec 10, 2025 | Class II | GET TESTED INTERNATIONAL AB Device |
Sorbitol Intolerance Test Distribution without premarket approval/clearance. FDA notice Z-0797-2026 |
| Dec 10, 2025 | Class II | GET TESTED INTERNATIONAL AB Device |
IBS Test Distribution without premarket approval/clearance. FDA notice Z-0784-2026 |
| Dec 10, 2025 | Class II | GET TESTED INTERNATIONAL AB Device |
Neurotransmitters XL Distribution without premarket approval/clearance. FDA notice Z-0791-2026 |
| Dec 10, 2025 | Class II | Philips North America Llc Device |
IntelliVue Patient Monitor MX450. Product Number: 866062. Potential issue where the IntelliVue monitors did not alarm. FDA notice Z-0863-2026 |
| Dec 10, 2025 | Class II | Aizu Olympus Co., Ltd. Device |
Olympus OER-Mini Inform existing affected device customers about pertinent Warnings/Cautions, existing recommended maintenance schedules and that only properly trained personnel conduct repairs and maintenance. FDA notice Z-0874-2026 |
| Dec 10, 2025 | Class II | GET TESTED INTERNATIONAL AB Device |
Melatonin Test Distribution without premarket approval/clearance. FDA notice Z-0812-2026 |
| Dec 10, 2025 | Class II | GET TESTED INTERNATIONAL AB Device |
Women s Hormone Test Distribution without premarket approval/clearance. FDA notice Z-0798-2026 |
| Dec 10, 2025 | Class II | Philips North America Llc Device |
IntelliVue Patient Monitor MX750. Product Number: 866471. Potential issue where the IntelliVue monitors did not alarm. FDA notice Z-0868-2026 |
| Dec 10, 2025 | Class II | GET TESTED INTERNATIONAL AB Device |
Fecal Occult Blood Test Distribution without premarket approval/clearance. FDA notice Z-0736-2026 |
| Dec 10, 2025 | Class II | GET TESTED INTERNATIONAL AB Device |
Epstein-Barr Virus (EBV VCA & EBNA IgG) Test Distribution without premarket approval/clearance. FDA notice Z-0735-2026 |
| Dec 10, 2025 | Class II | GET TESTED INTERNATIONAL AB Device |
Neurotransmitters Basic Distribution without premarket approval/clearance. FDA notice Z-0789-2026 |
| Dec 10, 2025 | Class II | Philips North America Llc Device |
IntelliVue Patient Monitor MX550. Product Number: 866066. Potential issue where the IntelliVue monitors did not alarm. FDA notice Z-0865-2026 |
| Dec 10, 2025 | Class II | Siemens Medical Solutions USA, Inc Device |
MAMMOMAT Revelation; There were instances where the operator table was sold together with a bus-installation kit. The operator table is not intended and not released for bus installations as it was designed for stationary operation only. FDA notice Z-0877-2026 |
| Dec 10, 2025 | Class II | GET TESTED INTERNATIONAL AB Device |
H pylori (Peptic ulcer) Test Distribution without premarket approval/clearance. FDA notice Z-0739-2026 |
| Dec 10, 2025 | Class II | GET TESTED INTERNATIONAL AB Device |
Men s Hormone Test Distribution without premarket approval/clearance. FDA notice Z-0788-2026 |
| Dec 10, 2025 | Class II | Aizu Olympus Co., Ltd. Device |
Olympus OER-Pro Inform existing affected device customers about pertinent Warnings/Cautions, existing recommended maintenance schedules and that only properly trained personnel conduct repairs and maintenance. FDA notice Z-0873-2026 |
| Dec 10, 2025 | Class II | GET TESTED INTERNATIONAL AB Device |
Food Sensitivity Test Medium Distribution without premarket approval/clearance. FDA notice Z-0761-2026 |
| Dec 10, 2025 | Class II | Accriva Diagnostics, Inc. Device |
Hemochron Activated Clotting Time Low-Range Test Cuvette, REF: ACT-LR, to be used with the Hemochron Signature ELITE Whole Blood Microcoagulation System Test cuvettes, used with an assay for monitoring heparin anticoagulation, may have a foreign object that has sharp edges and could pose a risk of injury if not detected prior to handling. FDA notice Z-0880-2026 |
| Dec 10, 2025 | Class II | Philips North America Llc Device |
IntelliVue Multi-Measurement Module X3. Product Number: 867030. Potential issue where the IntelliVue monitors did not alarm. FDA notice Z-0860-2026 |
| Dec 10, 2025 | Class II | GET TESTED INTERNATIONAL AB Device |
Ovulation Test (5 tests) Distribution without premarket approval/clearance. FDA notice Z-0747-2026 |
| Dec 10, 2025 | Class II | GET TESTED INTERNATIONAL AB Device |
Allergy & Food Intolerance Test Distribution without premarket approval/clearance. FDA notice Z-0802-2026 |
| Dec 10, 2025 | Class II | GET TESTED INTERNATIONAL AB Device |
Pregnancy Test Distribution without premarket approval/clearance. FDA notice Z-0749-2026 |
| Dec 10, 2025 | Class II | Philips North America Llc Device |
IntelliVue Patient Monitor MX400. Product Number: 866060. Potential issue where the IntelliVue monitors did not alarm. FDA notice Z-0862-2026 |